Third Annual Graciela Alarcón, MD, MPH lecture
Jane E. Salmon, MD
Professor of Medicine
Weill Cornell Medical College Collette Kean Research Professor Hospital for Special Surgery, New York, NY
Jane E. Salmon, MD will be the third Graciela S. Alarcón lecturer and will speak at Rheumatology Grand Rounds on Thursday, April 14 at 8:00 a.m. in West Pavilion Conference Room D. The title of her talk is “Mice and Mothers: Progress in Understanding Pregnancy Complications in Patients with Lupus and Antiphospholipid Syndrome”. This lecture honors Dr. Alarcón’s legacy in lupus research and her contributions to the UAB Division of Clinical Immunology and Rheumatology. There will also be a reception celebrating the establishment of the Graciela S. Alarcón, MD, MPH Endowed Support Fund for Lupus Research on Friday, April 15, 2016 from 12:00 pm to 1:30 PM in the Pittman Center for Advanced Medical Studies.
Dr. Salmon is Professor of Medicine and Professor of Obstetrics and Gynecology at Weill Cornell Medical College and the Collette Kean Research Professor at Hospital for Special Surgery. She graduated magna cum laude from New York University and earned a medical degree from the College of Physicians and Surgeons of Columbia University, where she was the first woman enrolled in their Medical Scientist Training Program. She completed training in internal medicine at The New York Hospital and in rheumatology at Hospital for Special Surgery, and has been an HSS faculty member since 1983. Dr. Salmon has served on the Board of Directors of the American College of Rheumatology and was co-editor of Arthritis & Rheumatism and is currently an Associate Editor of Annals of Rheumatic Diseases. At Hospital for Special Surgery, she is a Director of the Lupus and APS Center of Excellence, co-Director of the Mary Kirkland Center for Lupus Research, and Director of the FOCIS Center of Excellence. Dr. Salmon’s research has focused on elucidating mechanisms of tissue injury in lupus and other autoimmune diseases. Her basic and clinical studies have expanded our understanding of pregnancy loss and organ damage in SLE and the determinants of disease outcome in lupus patients with nephritis, pregnancy, and cardiovascular disease.